CVE-2025-7674
Improper Input Validation vulnerability in Roche Diagnostics navify Monitoring allows an attacker to manipulate input data, which may lead to a denial of service (DoS) due to negatively impacting the server's performance.
Does this matter?
High impact if exploited, but EPSS currently rates exploitation as unlikely (0.30%). Schedule it in the normal patch cycle and watch for a rise in EPSS or a public exploit.
Description
Improper Input Validation vulnerability in Roche Diagnostics navify Monitoring allows an attacker to manipulate input data, which may lead to a denial of service (DoS) due to negatively impacting the server's performance. This vulnerability has no impact on data confidentiality or integrity. This issue affects navify Monitoring before 1.08.00.
- CVSS 4.0
- 7.1 HIGHCVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:N/VI:N/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/M
- EPSS
- 0.30% probability · 23th percentile
- Public exploits
- None in Exploit-DB
- CISA KEV
- Not listed
- Weakness
- CWE-20
- Source
- 5cdcf916-2b10-4ec8-bfc1-d054821e439e
EPSS 0.3% since 26 October 2026; no change recorded yet. Points are recorded when the score first appears and whenever it moves by a percentage point or more.
Source: NVD record, EPSS from FIRST.org, KEV from CISA, exploits from Exploit-DB. Refreshed daily. Download this record as JSON.